Showing 1 - 18 results of 18 for search 'Jeffrey Schlom', query time: 0.03s Refine Results
  1. 1
    Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade

    Blood-based biomarkers in patients with non-small cell lung cancer treated with immune checkpoint blockade by Yo-Ting Tsai, Jeffrey Schlom, Renee N. Donahue

    Published 2024-03-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing

    Exploiting off-target effects of estrogen deprivation to sensitize estrogen receptor negative breast cancer to immune killing by Jeffrey Schlom, James W Hodge, Benjamin Wolfson, Michelle R Padget

    Published 2021-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management

    Early changes in immune cell subsets with corticosteroids in patients with solid tumors: implications for COVID-19 management by Renee N Donahue, Jeffrey Schlom, James L Gulley, Lisa Cordes, Jennifer L Marté, Nicole J Toney

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Serum analytes as predictors of disease recurrence and the duration of invasive disease-free survival in patients with triple negative breast cancer enrolled in the OXEL trial treated with immunotherapy, chemotherapy, or chemoimmunotherapy

    Serum analytes as predictors of disease recurrence and the duration of invasive disease-free survival in patients with triple negative breast cancer enrolled in the OXEL trial trea... by Renee N Donahue, Jeffrey Schlom, Nicole J Toney, Claudine Isaacs, Filipa Lynce, Candace Mainor, Megan T Lynch

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis

    Fulvestrant increases the susceptibility of enzalutamide-resistant prostate cancer cells to NK-mediated lysis by Jeffrey Schlom, Claudia Palena, Kristen Fousek, Duane H Hamilton, Lucas A Horn, Haiyan Qin, Madeline Dahut, Shantel Angstadt

    Published 2023-09-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines

    Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines by Renee N Donahue, Jeffrey Schlom, James L Gulley, James W Hodge, Claudia Palena, Duane H Hamilton, Sofia R Gameiro

    Published 2024-07-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody

    Analyses of the peripheral immunome following multiple administrations of avelumab, a human IgG1 anti-PD-L1 monoclonal antibody by Italia Grenga, Caroline Jochems, Massimo Fantini, James L. Gulley, Christopher R. Heery, Renee N. Donahue, Ravi A. Madan, Jeffrey Schlom, Lauren M. Lepone

    Published 2017-11-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific T cells and promotes tumor control

    Combination of a therapeutic cancer vaccine targeting the endogenous retroviral envelope protein ERVMER34-1 with immune-oncology agents facilitates expansion of neoepitope-specific... by Renee N Donahue, Jeffrey Schlom, James L Gulley, Claudia Palena, Duane H Hamilton, Masafumi Iida, Maria del Mar Maldonado, Maria Gracia-Hernandez, Loc Huu Le

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations

    PD-L1 targeting high-affinity NK (t-haNK) cells induce direct antitumor effects and target suppressive MDSC populations by Jeffrey Schlom, James W Hodge, Clint T. Allen, Shahrooz Rabizadeh, Patrick Soon-Shiong, John H. Lee, Renee N. Donahue, Kristen Solocinski, Michelle R Padget, Kellsye P Fabian, Yvette Robbins

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:
  10. 10
    Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer

    Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer by Jeffrey Schlom, Carl H. June, George A. Fisher, John J. Nemunaitis, Kristen M. Hege, Emily K. Bergsland, Robert S. Warren, James G. McArthur, Andy A. Lin, Stephen A. Sherwin

    Published 2017-01-01
    Get full text
    Article
    Save to List
    Saved in:
  11. 11
    Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy

    Combination of HDAC inhibition and cytokine enhances therapeutic HPV vaccine therapy by Jeffrey Schlom, James L Gulley, Caroline Jochems, Sofia R Gameiro, Wiem Lassoued, Daniel Burnett, Lisa K Poppe, Nicholas Roller, Miriam Marlene Medina-Enríquez, Katherine E Lothstein, Asma S Khelifa, Masaya Miyamoto

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  12. 12
    Case Report: The immune architecture of immunotherapy-induced cutaneous sarcoidosis resembles peritumoral inflammation

    Case Report: The immune architecture of immunotherapy-induced cutaneous sarcoidosis resembles peritumoral inflammation by Catherine J. Wang, Jennifer Strong, Margaret E. Gatti-Mays, Wiem Lassoued, Sam Sater, Julius Strauss, Jason M. Redman, Jason M. Redman, Jeffrey Schlom, James L. Gulley, Isaac Brownell, Isaac Brownell

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  13. 13
    Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity

    Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity by Jeffrey Schlom, Claudia Palena, Kristen Fousek, Zhen Su, Duane H Hamilton, Hanne Lind, Lucas A Horn, Jeffrey Riskin, Heidi A Hempel, Kristen K McCampbell, Dean Y Maeda, John A Zebala

    Published 2020-05-01
    Get full text
    Article
    Save to List
    Saved in:
  14. 14
    Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer

    Efficacy, safety, and biomarker analyses of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with advanced non-small cell lung cancer by Arun Rajan, Renee N Donahue, Jeffrey Schlom, James L Gulley, Elizabeth Lamping, Osama Rahma, Houssein Abdul Sater, Jennifer L Marté, Beatriz Walter-Rodriguez, Yulia Vugmeyster, Yo-Ting Tsai, Shania Bailey, Wiem Lassoued, Richy Agajanian, Andrew Weisman, Rena Ito, Masashi Sato, Andreas Machl

    Published 2024-03-01
    Get full text
    Article
    Save to List
    Saved in:
  15. 15
    Immunotherapy biomarkers 2016: overcoming the barriers

    Immunotherapy biomarkers 2016: overcoming the barriers by Jeffrey Schlom, Lisa H Butterfield, Jianda Yuan, Alessandra Cesano, Janet Siebert, Barbara Seliger, Jay A. Berzofsky, James L. Gulley, Holden Maecker, Bernard A. Fox, Marcus O. Butler, Cristina Maccalli, Sacha Gnjatic, Vaios Karanikas, Ilan Kirsch, Sylvia Janetzki, Samir N. Khleif, Magdalena Thurin, Peter P. Lee, Shyam Kalavar, David F. Stroncek

    Published 2017-08-01
    Get full text
    Article
    Save to List
    Saved in:
  16. 16
    PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer

    PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer by Charalampos S. Floudas, Meghali Goswami, Renee N. Donahue, Julius Strauss, Danielle M. Pastor, Jason M. Redman, Isaac Brownell, Evrim B. Turkbey, Seth M. Steinberg, Lisa M. Cordes, Jennifer L. Marté, Maheen H. Khan, Sheri McMahon, Elizabeth Lamping, Michell Manu, Manuk Manukyan, Douglas E. Brough, Amy Lankford, Caroline Jochems, Jeffrey Schlom, James L. Gulley

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  17. 17
    Programmed death-1 inhibition increases vaccine-induced T-cell infiltration in patients with prostate cancer

    Programmed death-1 inhibition increases vaccine-induced T-cell infiltration in patients with prostate cancer by Colin Pritchard, Renee N Donahue, Jeffrey Schlom, James L Gulley, Ravi A Madan, Fatima Karzai, Amy Hankin, Jennifer L Marté, Ismail Baris Turkbey, Yo-Ting Tsai, Manuk Manukyan, Moniquea Williams, William Dahut, Shania Bailey, Wiem Lassoued, Michell Manu, Peter Pinto, Daniel Burnett, Elisabetta Xue, Kenneth D Canubas, Antonios Papanicolau-Sengo, Zhigang Kang, Sam Sater

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  18. 18
    Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies

    Bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with human papillomavirus-associated malignancies by Renee N Donahue, Jeffrey Schlom, James L Gulley, Ravi A Madan, Caroline Jochems, Elizabeth Lamping, Julius Strauss, Marijo Bilusic, Fatima Karzai, Christian S Hinrichs, Edward McClay, Jennifer L Marté, Lisa M Cordes, Andrew Hill, Byoung Chul Cho, Sébastien Salas, Laureen S Ojalvo, P Alexander Rolfe, Margaret E Gatti-Mays, Jason M Redman, Houssein A Sater, Andrea Burmeister, Genevieve Jehl

    Published 2020-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: